UCB1381 / UCB 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UCB1381 / UCB
NCT05277571: A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Recruiting
1/2
152
US
UCB1381, Placebo
UCB Biopharma SRL
Atopic Dermatitis
07/25
10/25
NCT06716879: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of a Single Dose of Donzakimig in Healthy Chinese and Japanese Participants

Recruiting
1
42
US
Donzakimig, UCB1381, Placebo
UCB Biopharma SRL
Healthy Participants
03/25
03/25

Download Options